Prosecution Insights
Prosecution Insights
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §103 only | 2 (25%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEO, DUY VU NGUYEN | 1 | 82.4% | +7.0% |
| STAVROU, CONSTANTINA E | 1 | 44.2% | +36.3% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +40.1% |
| MUI, CHRISTINE T | 1 | 78.2% | +20.0% |
| KIM, YOUNG J | 1 | 64.8% | +18.0% |
| LOUIS, LATOYA M | 1 | 52.2% | +40.6% |
| WESTFALL, SARAH ANN | 1 | 0.0% | +0.0% |
| PARAS JR, PETER | 1 | 10.3% | +8.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17912331 | Attenuated Mycoplasma Bacteria | PARAS JR, PETER | 17d overdue |
| 18261205 | A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM | LOUIS, LATOYA M | 16d overdue |
| 18574352 | METHOD FOR MANUFACTURING AN EMITTER FOR ELECTROSPRAY GENERATORS | DEO, DUY VU NGUYEN | 63d |
| 18556456 | COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | KIM, YOUNG J | — |
| 18037191 | MEASURING AND IMPROVING ATTENTION | WESTFALL, SARAH ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261205 | A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM | LOUIS, LATOYA M | 16d overdue |
| 18562448 | SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS | STAVROU, CONSTANTINA E | — |
| 18556456 | COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18552385 | DRUG DISCOVERY ASSAY TO SCREEN FOR COMPOUNDS | MUI, CHRISTINE T | — |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | KIM, YOUNG J | — |
| Art Unit | Apps |
|---|---|
| 1713 | 1 |
| 1632 | 1 |
| 1622 | 1 |
| 1797 | 1 |
| 1681 | 1 |
| 3785 | 1 |
| 3791 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18574352 | METHOD FOR MANUFACTURING AN EMITTER FOR ELECTROSPRAY GENERATORS | DEO, DUY VU NGUYEN | 1713 | §103§112 | Non-Final OA | 63d | Pending | Dec 27, 2023 |
| 18562448 | SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS | STAVROU, CONSTANTINA E | 1632 | §103 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18556456 | COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §102§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18552385 | DRUG DISCOVERY ASSAY TO SCREEN FOR COMPOUNDS | MUI, CHRISTINE T | 1797 | §112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | KIM, YOUNG J | 1681 | §101§112 | Final Rejection | — | Pending | Aug 25, 2023 |
| 18261205 | A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM | LOUIS, LATOYA M | 3785 | §102§103§112 | Non-Final OA | 16d overdue | Pending | Jul 12, 2023 |
| 18037191 | MEASURING AND IMPROVING ATTENTION | WESTFALL, SARAH ANN | 3791 | §101§102§112 | Final Rejection | — | Pending | May 16, 2023 |
| 17912331 | Attenuated Mycoplasma Bacteria | PARAS JR, PETER | 1645 | §103 | Final Rejection | 17d overdue | Pending | Sep 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial